Big Gain For EyePoint Pharmaceuticals, Inc.
Fri, Apr 21, 2023 at 07:08 PM
EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ) rocketted at $9, representing a gain of 58.5%. On Fri, Apr 21, 2023, EYPT:NASDAQ hit a New 2-Week High of $9. The stock appeared on our News Catalysts scanner on Mon, Apr 17, 2023 at 08:24 AM in the 'MISCELLANEOUS' category. From Mon, Apr 10, 2023, the stock recorded 88.89% Up Days and 90.00% Green Days
About EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ)
pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.
Top 10 Gainers:
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 219.15%
- Mangoceuticals Inc. (MGRX:NASDAQ), 60.87%
- EyePoint Pharmaceuticals, Inc. (EYPT:NASDAQ), 58.45%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 53.52%
- Presto Automation Inc Com (PRST:NASDAQ), 36.23%
- CBL International Limited (BANL:NASDAQ), 34.75%
- Adial Pharmaceuticals, Inc. (ADIL:NASDAQ), 24.47%
- SRAX, Inc. (SRAX:NASDAQ), 24.39%
- Icosavax Inc. (ICVX:NASDAQ), 23.82%
- Tenaya Therapeutics Inc. (TNYA:NASDAQ), 22.79%